- Home
- SANG vs RPID Comparison
SANG vs RPID Comparison
Compare SANG & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- RPID
- Stock Information
- Founded
- SANG 1984
- RPID 2006
- Country
- SANG Canada
- RPID United States
- Employees
- SANG N/A
- RPID N/A
- Industry
- SANG Computer Software: Programming Data Processing
- RPID Medical Specialities
- Sector
- SANG Technology
- RPID Health Care
- Exchange
- SANG Nasdaq
- RPID Nasdaq
- Market Cap
- SANG 189.6M
- RPID 155.6M
- IPO Year
- SANG 2021
- RPID 2021
- Fundamental
- Price
- SANG $5.57
- RPID $3.64
- Analyst Decision
- SANG
- RPID Buy
- Analyst Count
- SANG 0
- RPID 1
- Target Price
- SANG N/A
- RPID $8.00
- AVG Volume (30 Days)
- SANG 8.0K
- RPID 160.9K
- Earning Date
- SANG 05-08-2025
- RPID 05-09-2025
- Dividend Yield
- SANG N/A
- RPID N/A
- EPS Growth
- SANG N/A
- RPID N/A
- EPS
- SANG N/A
- RPID N/A
- Revenue
- SANG $238,264,000.00
- RPID $29,645,000.00
- Revenue This Year
- SANG N/A
- RPID $18.54
- Revenue Next Year
- SANG $2.91
- RPID $20.55
- P/E Ratio
- SANG N/A
- RPID N/A
- Revenue Growth
- SANG N/A
- RPID 28.36
- 52 Week Low
- SANG $4.08
- RPID $0.58
- 52 Week High
- SANG $7.99
- RPID $4.04
- Technical
- Relative Strength Index (RSI)
- SANG 51.00
- RPID 69.34
- Support Level
- SANG $5.42
- RPID $3.15
- Resistance Level
- SANG $6.00
- RPID $3.84
- Average True Range (ATR)
- SANG 0.24
- RPID 0.25
- MACD
- SANG -0.05
- RPID 0.03
- Stochastic Oscillator
- SANG 27.03
- RPID 88.27
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.